We are live on
!
Find out more
RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$9.44B
1-Year Est. Return
68.42%
This Fund
S&P 500
This Quarter
Est. Return
+30.56%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$869M
AUM Growth
+$236M
(+37%)
Cap. Flow
+$134M
Cap. Flow
% of AUM
15.4%
Top 10 Holdings %
Top 10 Hldgs %
38.39%
Holding
74
New
22
Increased
12
Reduced
8
Closed
22
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ally Financial
ALLY
|
+$36.6M |
| 2 |
OPLN
Openlane
OPLN
|
+$28.8M |
| 3 |
Outfront Media
OUT
|
+$24.2M |
| 4 |
Par Pacific Holdings
PARR
|
+$22.4M |
| 5 |
Rithm Capital
RITM
|
+$22.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$36.5M |
| 2 |
CVS Health
CVS
|
+$32.4M |
| 3 |
Coherus Oncology
CHRS
|
+$25.7M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$22.9M |
| 5 |
VICI Properties
VICI
|
+$21.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.91% |
| 2 | Healthcare | 19.16% |
| 3 | Financials | 10.09% |
| 4 | Communication Services | 8.11% |
| 5 | Real Estate | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PennyMac Financial
PFSI
$3.98B
| $17.2M | 1.98% |
+411,185
| New | +$13M |
|
|
BMY.RT
27
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $17M | 1.95% |
4,744,695
+2,109,501
| +80% | +$7.61M |
|
|
RDUS
28
DELISTED
Radius Health, Inc.
RDUS
| $16.7M | 1.93% |
1,227,929
| – | – |
|
|
DOO
29
Bombardier Recreational Products
DOO
$4.79B
| $16.3M | 1.87% |
+381,197
| New | +$11.4M |
|
30
Tenet Healthcare
THC
$20.9B
| $15.5M | 1.78% |
+856,176
| New | +$16.9M |
|
31
BGC Group
BGC
$4.83B
| $11.6M | 1.34% |
4,246,521
-1,531,670
| -27% | -$4.24M |
|
32
TherapeuticsMD
TXMD
$24M
| $11.6M | 1.34% |
185,705
-6,532
| -3% | -$380K |
|
|
COOP
33
DELISTED
Mr. Cooper
COOP
| $11.2M | 1.29% |
900,031
+178,190
| +25% | +$1.79M |
|
34
PUT
Apollo Global Management
APO
$82.8B
| $11M | 1.26% |
220,000
| – | – |
|
35
Clear Channel Outdoor Holdings
CCO
$1.23B
| $10.7M | 1.23% |
10,280,599
+280,599
| +3% | +$264K |
|
36
Genesco
GCO
$409M
| $9.71M | 1.12% |
+448,475
| New | +$8.28M |
|
|
TPIC
37
DELISTED
TPI Composites
TPIC
| $9.53M | 1.1% |
+407,696
| New | +$7.65M |
|
38
Lesaka Technologies
LSAK
$414M
| $6.48M | 0.75% |
2,132,622
-784,869
| -27% | -$2.64M |
|
|
ORBC
39
DELISTED
ORBCOMM, Inc.
ORBC
| $6.45M | 0.74% |
1,673,971
| – | – |
|
|
IPHA
40
Innate Pharma
IPHA
$202M
| $6.38M | 0.73% |
931,673
| – | – |
|
41
Immersion
IMMR
$248M
| $5.75M | 0.66% |
922,222
| – | – |
|
|
OSG
42
Octave Specialty Group
OSG
$205M
| $5.06M | 0.58% |
+353,472
| New | +$5.17M |
|
|
SCTL
43
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $4.9M | 0.56% |
+1,076,587
| New | +$6.66M |
|
|
HUD
44
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $4.5M | 0.52% |
+925,043
| New | +$4.83M |
|
|
MINI
45
DELISTED
Mobile Mini Inc
MINI
| $4.34M | 0.5% |
146,974
-20,000
| -12% | -$596K |
|
46
Laureate Education
LAUR
$5.05B
| $3.97M | 0.46% |
+398,557
| New | +$3.86M |
|
|
KDNY
47
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $3.76M | 0.43% |
325,864
+151,644
| +87% | +$2.09M |
|
|
ASRT
48
DELISTED
Assertio
ASRT
| $2.96M | 0.34% |
57,527
| – | – |
|
49
Adeia
ADEA
$3.06B
| $2.95M | 0.34% |
+755,977
| New | +$2.86M |
|
|
SIOX
50
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $1.3M | 0.15% |
460,200
| – | – |
|
Similar funds
RCM
SIM
NPT
AC
PVI
WPL
IAA
LAMI
Rubric Capital Management (New York)'s Q2 2020 Portfolio in Review
As of Q2 2020, Rubric Capital Management (New York) held 74 positions worth $869M, up 37% from $633M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Rubric Capital Management (New York) deployed $134M of net new capital in Q2 2020, opening 22 new positions and adding to 12 existing holdings. Its largest new stake was Ally Financial: 2,150,000 shares worth $42.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Talend S.A. American Depositary Shares, an estimated $14M trimmed.
- Rubric Capital Management (New York)'s largest Q2 2020 buy was Ally Financial: 2,150,000 shares worth $42.6M.
- Rubric Capital Management (New York) added most to PG&E in Q2 2020, an estimated $18.3M increase.
- Rubric Capital Management (New York)'s biggest Q2 2020 reduction was Talend S.A. American Depositary Shares, cutting an estimated $14M.
- Rubric Capital Management (New York) fully exited Centene in Q2 2020, selling an estimated $36.5M.
- Rubric Capital Management (New York)'s ten largest holdings make up 38% of its $869M portfolio in Q2 2020.
- Rubric Capital Management (New York) opened 22 new positions and closed 22 in Q2 2020.
- Rubric Capital Management (New York)'s portfolio value rose 37% quarter-over-quarter to $869M.
Based on Rubric Capital Management (New York)'s 13F filing for Q2 2020, filed 10 Aug 2020.